R. Rosell
Chief Scientific Officer, Chairman,
treatment of cancer.
Precision Oncology
Spain
Biography
Rafael Rosell, MD PhD Chief Scientific Officer, Chairman, Co-Founder Rafael Rosell, MD, PhD, is also founder of the Spanish Lung Cancer Group, President and Director of the Cancer Biology and Precision Medicine Program at the Catalan Institute of Oncology (ICO). Dr Rosell’s contributions to translational medical oncology, with particular emphasis on the field of non-small-cell lung cancer with EGFR mutations, have earned him international recognition: in 2013 he was recognized by The Lancet as the highest authority in lung cancer in Europe, and he has received numerous awards in recognition of his tireless investigations into the causes and treatment of cancer. Rafael Rosell, MD PhD Chief Scientific Officer, Chairman, Co-Founder Rafael Rosell, MD, PhD, is also founder of the Spanish Lung Cancer Group, President and Director of the Cancer Biology and Precision Medicine Program at the Catalan Institute of Oncology (ICO). Dr Rosell’s contributions to translational medical oncology, with particular emphasis on the field of non-small-cell lung cancer with EGFR mutations, have earned him international recognition: in 2013 he was recognized by The Lancet as the highest authority in lung cancer in Europe, and he has received numerous awards in recognition of his tireless investigations into the causes and treatment of cancer.
Research Interest
non-small-cell lung cancer with EGFR mutations,
